SCHEMBL30120243

SCHEMBL30120243

Nc1ccc(C2CCC3(CC2)OCCO3)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.35
OPRL1 P41146 7/20 0.35
TRPV3 Q8NET8 1/20 0.34
MAPK1 P28482 2/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
IKBKE Q14164 1/20 0.32
TBK1 Q9UHD2 1/20 0.32
CRBN Q96SW2 1/20 0.32
PDE10A Q9Y233 2/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNA4 P43681 1/20 0.32
MAPT P10636 2/20 0.31
MEN1 O00255 1/20 0.31
MITF O75030 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24753039 1.00 MAOA (0.35) MAOAOPRL1TRPV3MAPK1NPC1
SCHEMBL22816456 0.84 OPRL1 (0.45) OPRL1TRPV3MAPK1NPC1RAB9A
SCHEMBL17542866 0.82 OPRL1 (0.47) OPRL1TRPV3NPC1RAB9AMAPT
SCHEMBL29932014 0.82 OPRL1 (0.47) OPRL1TRPV3NPC1RAB9AMAPT
SCHEMBL24215291 0.81 QPCT (0.36) MAOAOPRL1MAPK1CRBNCHRNB2
SCHEMBL12474719 0.80 TRPV3 (0.33) TRPV3MAPK1NPC1RAB9AIKBKE
SCHEMBL30084892 0.80 CHRNB2 (0.41) MAOAOPRL1MAPK1CRBNCHRNB2
SCHEMBL13014935 0.80 CHRNB2 (0.41) MAOAOPRL1MAPK1CRBNCHRNB2
SCHEMBL22089867 0.79 MAOA (0.50) MAOAOPRL1MAPK1CHRNB2CHRNA4
SCHEMBL1528692 0.79 TRPV3 (0.35) OPRL1TRPV3MAPK1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096858-A1 COMPOUNDS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
EP-4351583-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 Therapeutics, Inc. (US) 2024-04-17 EP disclosed
WO-2022261250-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed